Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06821880
What this trial is testing

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck 120
Not applicableActive Not RecruitingNCT06452446
What this trial is testing

Telehealth-based Symptom Management for Veterans Treated With Selinexor

Who this might be right for
Multiple MyelomaLarge-cell Lymphoma
Durham VA Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07075510
What this trial is testing

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Maryland, Baltimore 30
Testing effectiveness (Phase 2)Study completedNCT02213913
What this trial is testing

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Diffuse Large Cell Lymphoma+69 more
University of Chicago 55
Large-scale testing (Phase 3)Looking for participantsNCT07346859
What this trial is testing

Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency Diseases
Biopharma Plasma LLC 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07090954
What this trial is testing

GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 32
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Early research (Phase 1)UnknownNCT01843686
What this trial is testing

Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns

Who this might be right for
Acute Burns
Arteriocyte, Inc. 42
Not applicableStudy completedNCT03044431
What this trial is testing

Autologous Stem Cell Treatment for Chronic Lung Disease Study

Who this might be right for
COPDInterstitial Lung Disease
Lung Institute 207
Early research (Phase 1)Study completedNCT01582295
What this trial is testing

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 4
Not applicableStudy completedNCT03716141
What this trial is testing

Autologous Platelets Rich Plasma (APRP) Treatment Vs Saline Dressing for the Management of Diabetic Foot Ulcer

Who this might be right for
Diabetic Foot Ulcer
Services Hospital, Lahore 100
Testing effectiveness (Phase 2)Study completedNCT00095277
What this trial is testing

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

Who this might be right for
Anemia
Amgen 220
Not applicableStudy completedNCT06323902
What this trial is testing

Autologous Platelet-rich Plasma as a Treatment for Macular Holes

Who this might be right for
Macular HolesMacular Hole of Left Eye (Disorder)Macular Hole of Right Eye (Disorder)
Clinica Oftalmologica Paredes 13
Not applicableUnknownNCT03328728
What this trial is testing

Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Regen Lab SA 190
Not applicableNot Yet RecruitingNCT07730645
What this trial is testing

Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2 (CIN2)Cervical Intraepithelial Neoplasia Grade 2CIN2
University Hospital Tuebingen 264
Post-approval studies (Phase 4)Study completedNCT01022736
What this trial is testing

Plasma Gabapentin Concentration During and Following Cardiac Bypass

Who this might be right for
Cardiopulmonary Bypass
Queen's University 16
Not applicableUnknownNCT04365439
What this trial is testing

Convalescent Plasma for COVID-19

Who this might be right for
Blood Plasma TherapyCOVID
Enos Bernasconi 11
Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Not applicableLooking for participantsNCT06933277
What this trial is testing

Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

Who this might be right for
Multiple Myeloma
Gruppo Italiano Malattie EMatologiche dell'Adulto 159
Next Page